[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/sci/ - Science & Math

Search:


View post   

>> No.15601878 [View]
File: 151 KB, 1080x1350, Angie-Varona-Lara-Croft-Cosplay-Onlyfans-Set-Leaked.jpg [View same] [iqdb] [saucenao] [google]
15601878

>>15601864
a brief summary, if you dont wanna click

[1. ON THE VACCINE]
[VAX INEFFECTIVITY]
[VACCINE EFFECT ON MORTALITY - Randomised Clinial Trials]
[VAX DAMAGE METAREVIEWS]
[MONOCLONAL ANTIBODIES, IVERMECTIN, PAXLOVID, MOLNUPIRAVID, REMDESIVIR EFFECTIVENESS]
[EVOLUTIONARY PRESSURE leads to MORE VIRULENT VARIANTS]
[DEATHS BY SECONDARY PNEUMONIA in HOSPITALS - SARS-COV2+PNEUMONIA as a MASS KILLER]

[2. ON THE VACCINE COMPONENTS]
[SPIKE PROTEIN]
[LIPID NANOPARTICLES]
[BACTERIAL DNA CONTAMINATION in the VACCINE]
[FOREIGN MATERIALS in the VACCINE]

[3. VACCINE SHEDDING]
[VIRAL SHEDDING]
[VACCINE SHEDDING]
[MATERNAL TRANSMISSION TO THE FETUS/BABY]

[4. REVERSE TRANSCRIPTION - (YES, GENE EDITING EXISTS), DNA reverse transcription, NEVER STOPS REPLICATING: 3UTR 5UTR SHENANIGANS]

[5. SIDE EFFECTS]
[#]
[5A. SHORT TERM EFFECTS (a MONTH)]
[BLOODCLOTS/STROKES/THROMBOSIS]
[MYOCARITIS/HEART ATTACKS]
[ABORTIONS, MISCARRIAGES, PROBLEMS during PREGNANCY]
[EMBOLISMS/ENDOTHELIAL DAMAGE]
[ACTIVATION OF OTHER VIRUSES, COINFECTIONS]
[#]
[5B. MEDIUM TERM EFFECTS (a YEAR)]
[OAS - Original antigenic sin]
[ADE - Antibody-dependent enhancement]
[ADCC - Antibody-dependent cellular cytotoxicity]
[MODIFIED IMMUNE RESPONSE - VAIDS Vaccine-Acquired Immune Deficiency Syndrome, T-Cell Exhaustion, Autoimmune Disorders, Immune Response Shift to IgG4]
[#]
[5C. LONG TERM EFFECTS (a DECADE)]
[PRION DISEASES]
[AMYLOIDOSIS - ALZHEIMER - infection, spike, treatments]
[CANCER - DNA damage, inflamation-driven cancer, impaired T-Cell response, p53-tumor suppresor gene blocking mechanism]
[SUPRESSION DNA REPAIR MECHANISM - Non-homologous end joining (NHEJ)]
[INFERTILITY/REPRODUCTIVE DISORDERS - menstrual problems, pregnancy and miscarriage, placenta, maternal transmission, testes]
[CELLULLAR SENESCENCE - Ciliopathy,telomere dysfunction]

[6. AND NOW WHAT?]
[POSSIBLE TREATMENTS]
[BETTER RESEARCH - STUDY DESIGNS, ADEQUATE USE OF STATISTICS]
[ON GOF RESEARCH]
[OTHERS]

>> No.15439428 [View]
File: 151 KB, 1080x1350, Angie-Varona-Lara-Croft-Cosplay-Onlyfans-Set-Leaked.jpg [View same] [iqdb] [saucenao] [google]
15439428

>>15438872
glad you asked

>autoimmunity clots in adenovirus-vaccines
https://pubmed.ncbi.nlm.nih.gov/35486845/
Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration
Nicolai et al

>S1 is sufficient to propagate inflammatory and thrombogenic processes in the microvasculature:
https://www.frontiersin.org/articles/10.3389/fimmu.2022.827146/full
SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
Perico et al

https://www.biorxiv.org/content/10.1101/2021.10.12.464152v1
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy
Ryu et al

https://pubmed.ncbi.nlm.nih.gov/35891400/
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Nunez-Castilla et al
Antibodies cross-reacting with thrombopoietin may induce thrombocytopenia, a condition observed in COVID-19 patients.

>case report
https://pubmed.ncbi.nlm.nih.gov/34839563/
Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination
Kuzumi et al

>S1 is sufficient to propagate inflammatory and thrombogenic processes in the microvasculature:
https://www.frontiersin.org/articles/10.3389/fimmu.2022.827146/full
SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
Perico et al

https://www.sciencedirect.com/science/article/pii/S0264410X22014931
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older
Wong et al
rate ratios (RR) of observed outcome rates compared to historical (or expected) rates prior to COVID-19 vaccination.
pulmonary embolism (PE; RR = 1.54),
acute myocardial infarction (AMI; RR = 1.42),
disseminated intravascular coagulation (DIC; RR = 1.91),
and immune thrombocytopenia (ITP; RR = 1.44).

and CTRL+F "thromb" here:
https://textup.fr/703201hO

Navigation
View posts[+24][+48][+96]